Hypertension Guidelines: The Threads That Bind Them.

[1]  J. Spertus,et al.  Low Diastolic Blood Pressure Is Associated With Angina in Patients With Chronic Coronary Artery Disease. , 2018, Journal of the American College of Cardiology.

[2]  G. Lip,et al.  Ideal Blood Pressure in Patients With Atrial Fibrillation. , 2018, Journal of the American College of Cardiology.

[3]  G. Lip,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[4]  Jackson T. Wright,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American College of Cardiology.

[5]  Alexander G Logan,et al.  Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. , 2018, The Canadian journal of cardiology.

[6]  Leif E. Peterson,et al.  Impact of Cardiovascular Risk on the Relative Benefit and Harm of Intensive Treatment of Hypertension. , 2018, Journal of the American College of Cardiology.

[7]  R. Brook,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.

[8]  P. Whelton,et al.  Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control , 2018, Circulation.

[9]  I. D. de Boer,et al.  Diabetes and Hypertension: A Position Statement by the American Diabetes Association , 2017, Diabetes Care.

[10]  P. Whelton,et al.  Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment. , 2017, Journal of the American College of Cardiology.

[11]  R. Phillips.  Hypertension Treatment and Outcomes in the Era of Population Health, Coordinated Care, and Medicare Access and CHIP Reauthorization Act (MACRA) , 2017, Circulation.

[12]  T. Wilt,et al.  Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians , 2017, Annals of Internal Medicine.

[13]  D. Lloyd‐Jones,et al.  Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention , 2017, Hypertension.

[14]  A. Schuler,et al.  Cost-effectiveness of Intensive Blood Pressure Management. , 2016, JAMA cardiology.

[15]  J. Coresh,et al.  60 A comparison of HFrEF vs HFpEF’s clinical workload and cost in the first year following hospitalisation and enrollment in a disease management program , 2016, Journal of the American College of Cardiology.

[16]  L. Krakoff,et al.  Blood Pressure Variability: Insights From "Big Data". , 2016, Journal of the American College of Cardiology.

[17]  Deepak L. Bhatt,et al.  Pulse Pressure and Risk for Cardiovascular Events in Patients With Atherothrombosis: From the REACH Registry. , 2016, Journal of the American College of Cardiology.

[18]  S. Oparil,et al.  The J-curve phenomenon revisited again: SPRINT outcomes favor target systolic blood pressure below 120 mmHg , 2016, Blood pressure.

[19]  D. Goff,et al.  Identifying Individuals at Risk for Cardiovascular Events Across the Spectrum of Blood Pressure Levels , 2015, Journal of the American Heart Association.

[20]  J. Ioannidis,et al.  Nationwide Population Science: Lessons From the Taiwan National Health Insurance Research Database. , 2015, JAMA internal medicine.

[21]  M. Woodward,et al.  Blood pressure lowering and cardiovascular risk – Authors' reply , 2014, The Lancet.

[22]  M. Woodward,et al.  Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data , 2014, The Lancet.

[23]  R. Brook,et al.  Comparison of the Treatment Implications of American Society of Hypertension and International Society of Hypertension 2013 and Eighth Joint National Committee Guidelines: An Analysis of National Health and Nutrition Examination Survey , 2014, Hypertension.

[24]  Jennifer G. Robinson,et al.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[25]  Jennifer G. Robinson,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[26]  R. Hayward,et al.  Providing clinicians with a patient’s 10-year cardiovascular risk improves their statin prescribing: a true experiment using clinical vignettes , 2013, BMC Cardiovascular Disorders.

[27]  Li-sheng Liu,et al.  Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.

[28]  C. Bulpitt,et al.  On-treatment diastolic blood pressure and prognosis in systolic hypertension. , 2007, Archives of internal medicine.

[29]  G. Mancia,et al.  Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? , 2006, Annals of Internal Medicine.

[30]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[31]  C. Bulpitt,et al.  Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension , 2000, Circulation.

[32]  Karla Kerlikowske,et al.  Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials , 2000, The Lancet.

[33]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[34]  Thomas Kahan,et al.  [2018 ESC/ESH Guidelines for the management of arterial hypertension]. , 2019, Kardiologia polska.

[35]  Deepak L. Bhatt,et al.  Relationships Between Components of Blood Pressure and Cardiovascular Events in Patients with Stable Coronary Artery Disease and Hypertension , 2018, HYPERTENSION.

[36]  Jennifer G. Robinson,et al.  Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. , 2013, Journal of the American Pharmacists Association : JAPhA.

[37]  Judith S. Hochman,et al.  Reprint: 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. , 2013, Journal of the American Pharmacists Association : JAPhA.

[38]  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. , 1991, JAMA.